Are glucagon-like peptide-1 receptor agonists the functional cure for patients with metabolic dysfunction-associated cirrhosis?
ALIMENTARY PHARMACOLOGY & THERAPEUTICS(2024)
摘要
LINKED CONTENT This article is linked to Elsaid et al paper. To view this article, visit
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要